stockrowCronos Group Inc. (CRON) vs Xeris Biopharma Holdings, Inc. (XERS)
- Cronos Group Inc. CRON 3.72 +5.98%
- Xeris Biopharma Holdings, Inc. XERS 12.95 +23.80%
Cronos Group Inc. and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $2.4B against $1.4B — 1.7× the size. Xeris Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Cronos Group Inc. trades at 21.9×. Cronos Group Inc. grew revenue faster over the last twelve months: 55.8% against 38.4%. Cronos Group Inc. has the higher net margin (28.0% vs −1.76%) and the lower return on invested capital (1.28% vs 27.2%). Across the 20 metrics below, Cronos Group Inc. leads on 13 and Xeris Biopharma Holdings, Inc. on 7.
Valuation
Profitability
| Metric | CRON | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.59% | 87.38% | 53.51% |
| Operating margin | 3.78% | 12.70% | 0.00% |
| Net margin | 28.04% | (1.76%) | (2.45%) |
| Free cash flow margin | 31.71% | 20.00% | 0.00% |
| Return on equity | 5.12% | (27.11%) | (0.80%) |
| Return on assets | 4.87% | (1.64%) | (1.67%) |
| Return on invested capital | 1.28% | 27.22% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack